Showing results (31-40 of 108) with videos related to
Sort By:
Pageof 11
Research and Practice in Thrombosis and Haemostasis|January 15, 2025
Extending health equity to people with moderate and mild hemophilia A: revisiting the HAVEN 6 trialCedric Hermans, Michiel Coppens, Giuliana Ventriglia, et al.Blood|July 12, 2015
Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserineGary E Gilbert, Valerie A Novakovic, Jialan Shi, et al.Blood|May 23, 2012
Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activityGary E Gilbert, Valerie A Novakovic, Randal J Kaufman, et al.Journal of Comparative Effectiveness Research|October 22, 2021
Estimating the risk of thrombotic events in people with congenital hemophilia A using US claims dataImi Faghmous, Francis Nissen, Peter Kuebler, et al.The Journal of Biological Chemistry|November 8, 2001
Four hydrophobic amino acids of the factor VIII C2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifsGary E Gilbert, Randal J Kaufman, Andrew A Arena, et al.Current Gene Therapy|September 16, 2022
Characteristics of BAY 2599023 in the Current Treatment Landscape of Hemophilia A Gene TherapySteven W Pipe, Valder R Arruda, Claudia Lange, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|November 20, 2020
Management of COVID-19-associated coagulopathy in persons with haemophiliaSteven W Pipe, Radoslaw Kaczmarek, Alok Srivastava, et al.Blood|September 3, 2016
Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia ASteven W Pipe, Robert R Montgomery, Kathleen P Pratt, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2009
Suppression of FVIII inhibitor formation in hemophilic mice by delivery of transgene modified apoptotic fibroblastsRui-Jun Su, Angela Epp, Yvette Latchman, et al.Journal of Thrombosis and Haemostasis : JTH|November 3, 2011
Bioengineering of coagulation factor VIII for efficient expression through elimination of a dispensable disulfide loopS R Selvaraj, A N Scheller, H Z Miao, et al.Pageof 11